Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioLine RX Ltd ADR buy BiotechBee

Start price
€1.97
03.09.23 / 50%
Target price
€2.50
31.07.25
Performance (%)
18.78%
End price
€2.34
06.09.23
Summary
This prediction ended on 06.09.23 with a price of €2.34. The prediction had a final performance of 18.78%. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
BioLine RX Ltd ADR 7.563% 7.563%
iShares Core DAX® 2.831% 1.236%
iShares Nasdaq 100 2.918% 0.640%
iShares Nikkei 225® 2.007% -2.135%
iShares S&P 500 2.257% 0.451%

According to BiotechBee what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread BioLine RX Ltd ADR diskutieren
Prediction Buy
Perf. (%) 18.78%
Target price 2.500
Change
Ends at 31.07.25

Buy mit Kursziel 2,5